Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: A retrospective review of 63 cases

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 563-568

  Goo, B ^a   Chung, H J ^a   Chung, W G ^a   Chung, K Y ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Folliculitis; Folliculitis decalvans; Furunculosis; Hidradenitis suppurativa; Human immunoglobulin; Intramuscular injection

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; CHRONIC RECURRENT FURUNCULOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLICULITIS; FOLLICULITIS DECALVAN; FURUNCULOSIS; HOSPITAL; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INJECTION SITE PAIN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; PHARMACY; PHYSICIAN; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SKIN DISEASE; SUPPURATIVE HIDRADENITIS;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34547855147     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08069.x     Document Type: Review

References (35)

1. Mimouni D, Gdalevich M, Mimouni FB et al. Does immune serum globulin confer protection against skin diseases? Int J Dermatol 2000 39 : 628 31.
2. Bayry J, Thirion M, Misra N et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol Sci 2003 24 (Suppl. 4 S217 21.
3. Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther 2004 17 : 50 4.
4. Jemec GB, Faber M, Gutschik E et al. The bacteriology of hidradenitis suppurativa. Dermatology 1996 193 : 203 6.
5. Bacterial infections. In : Andrews' Diseases of the Skin (Odom RB, James WD, Berger TG, eds 9th edn. Philadelphia : W.B. Saunders Company, 2000 307 57.
6. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ 1989 298 : 28 9.
7. Mortimer PS, Dawber RP, Gales MA et al. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986 115 : 263 8.
8. Sawers RS, Randall VA, Ebling FJ. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy. Br J Dermatol 1986 115 : 269 74.
9. Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996 134 : 1057 9.
10. O'Loughlin S, Woods R, Kirke PN et al. Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients. Arch Dermatol 1988 124 : 1043 6.
11. Morell A, Schurch B, Ryser D et al. In vivo behaviour of gamma globulin preparations. Vox Sang 1980 38 : 272 83.
12. Knable AL. Micellaneous systemic drugs. In : Comprehensive Dermatologic Drug Therapy (Wolverton SE, ed 1st edn. Philadelphia : W.B. Saunders Company, 2001 457 60.
13. Morell A, Skvaril F. Structure and biological properties of immunoglobulins and gamma-globulin preparations. II. Properties of gamma-globulin preparations. Schweiz Med Wochenschr 1980 110 : 80 5.
14. Weiler CR. Immunoglobulin therapy: history, indications, and routes of administration. Int J Dermatol 2004 43 : 163 6.
15. Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998 134 : 80 6.
16. Chan-Lam D, Fitzsimons EJ, Douglas WS. Alopecia after immunoglobulin infusion. Lancet 1987 i : 1436.
17. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev 2003 17 : 241 51.
18. Dahl MV, Bridges AG. Intravenous immune globulin: fighting antibodies with antibodies. J Am Acad Dermatol 2001 45 : 775 83.
19. Wu CG, Mason B, Jong J et al. Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 2005 45 : 1003 10.
20. Yu MW, Mason BL, Guo ZP et al. Safety of intravenous immunoglobulin with regard to hepatitis C virus. Clin Ther 1996 18 (Suppl. B 71 2.
21. Yu MW, Mason BL, Guo ZP et al. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 1995 345 : 1173 4.
22. Demircay Z, Eksioglu-Demiralp E, Ergun T et al. Phagocytosis and oxidative burst by neutrophils in patients with recurrent furunculosis. Br J Dermatol 1998 138 : 1036 8.
23. Forte WC, Noyoya AM, de Carvalho Junior FF et al. Repeated furunculosis in adult male with abnormal neutrophil activity. Allergol Immunopathol (Madr) 2000 28 : 328 31.
24. Levy R, Shriker O, Porath A et al. Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions. J Infect Dis 1996 173 : 1502 5.
25. Levy R, Schlaeffer F. Successful treatment of a patient with recurrent furunculosis by vitamin C: improvement of clinical course and of impaired neutrophil functions. Int J Dermatol 1993 32 : 832 4.
26. McDaniel DH, Welton WA. Furunculosis and hidradenitis suppurativa response. Arch Dermatol 1984 120 : 437.
27. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004 8 : 77 89.
28. Ah-Weng A, Langtry JA, Velangi S et al. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol 2005 30 : 669 71.
29. Buckley DA, Rogers S. Cyclosporin-responsive hidradenitis suppurativa. J R Soc Med 1995 88 : P289 90.
30. Jemec GB. What's new in hidradenitis suppurativa? J Eur Acad Dermatol Venereol 2000 14 : 340 1.
31. Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg 2003 7 : 47 56.
32. Acne. In : Andrews' Diseases of the Skin (Odom RB, James WD, Berger TG, eds 9th edn. Philadelphia : W.B. Saunders Company, 2000 284 306.
33. Bourne HR, Melmon KL, Lichtenstein LM. Histamine augments leukocyte adenosine 3′,5′-monophosphate and blocks antigenic histamine release. Science 1971 173 : 743 5.
34. Bourne HR, Lichtenstein LM, Melmon KL. Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3′,5′-adenosine monophosphate in human leukocytes. J Immunol 1972 108 : 695 705.
35. Ishikawa T, Shimada T, Kessoku N et al. Inhibition of rat mast cell degranulation and histamine release by histamine-rat gammaglobulin conjugate. Int Arch Allergy Appl Immunol 1979 59 : 403 7.